Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
As of close of business last night, Insmed Inc’s stock clocked out at $72.75, up 3.63% from its previous closing price of $70.20. In other words, the price has increased by $3.63 from its previous closing price. On the day, 2.26 million shares were traded. INSM stock price reached its highest trading level at $73.22 during the session, while it also had its lowest trading level at $69.04.
Ratios:
To gain a deeper understanding of INSM’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.99 and its Current Ratio is at 6.37. In the meantime, Its Debt-to-Equity ratio is 2.41 whereas as Long-Term Debt/Eq ratio is at 2.38.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on April 23, 2024, initiated with a Buy rating and assigned the stock a target price of $48.
On February 15, 2024, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $42.
On December 08, 2023, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $55.Wells Fargo initiated its Overweight rating on December 08, 2023, with a $55 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 14 ’25 when Flammer Martina M.D. sold 1,384 shares for $68.72 per share. The transaction valued at 95,108 led to the insider holds 100,165 shares of the business.
Adsett Roger sold 1,457 shares of INSM for $100,125 on Jan 14 ’25. The Chief Operating Officer now owns 146,082 shares after completing the transaction at $68.72 per share. On Jan 14 ’25, another insider, Schaeffer Orlov S Nicole, who serves as the Chief People Strategy Officer of the company, sold 872 shares for $68.72 each. As a result, the insider received 59,924 and left with 97,083 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INSM now has a Market Capitalization of 13015193600 and an Enterprise Value of 12707181568. For the stock, the TTM Price-to-Sale (P/S) ratio is 37.95 while its Price-to-Book (P/B) ratio in mrq is 26.92. Its current Enterprise Value per Revenue stands at 37.052 whereas that against EBITDA is -18.282.
Stock Price History:
The Beta on a monthly basis for INSM is 1.11, which has changed by 1.5982144 over the last 52 weeks, in comparison to a change of 0.22677135 over the same period for the S&P500. Over the past 52 weeks, INSM has reached a high of $80.53, while it has fallen to a 52-week low of $21.92. The 50-Day Moving Average of the stock is 2.16%, while the 200-Day Moving Average is calculated to be 17.03%.
Shares Statistics:
It appears that INSM traded 1.65M shares on average per day over the past three months and 2156810 shares per day over the past ten days. A total of 178.85M shares are outstanding, with a floating share count of 174.60M. Insiders hold about 2.40% of the company’s shares, while institutions hold 105.94% stake in the company. Shares short for INSM as of 1735603200 were 15440877 with a Short Ratio of 9.34, compared to 1732838400 on 12616116. Therefore, it implies a Short% of Shares Outstanding of 15440877 and a Short% of Float of 8.74.
